Abstract
Epilepsy, a complex neurological disorder characterized by recurrent seizures, poses significant challenges to patients and healthcare providers alike.1 Pharmacotherapy remains a cornerstone of epilepsy treatment, and the paper explores the latest advancements in antiepileptic drugs (AEDs), highlighting novel agents and their mechanisms of action.2 Additionally, it discusses the challenges posed by drug-resistant epilepsy and explores alternative treatment options, such as neurostimulation and neuromodulation devices. Innovative techniques, such as deep brain stimulation (DBS) and vagus nerve stimulation (VNS) are reviewed in detail, emphasizing their potential as adjunctive therapies for seizure control. Surgical interventions, including resective surgery, laser interstitial thermal therapy (LITT), and functional hemispherectomy, are discussed as viable options for patients with medication-resistant epilepsy.3 This review aims to provide an encompassing exploration of types and characteristics of treatment products, and an in-depth analysis of the market, including market size, distribution, and current trends. Additionally, it will conclude by presenting an overview of emerging approaches in epilepsy treatment for potential clinical applications.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Advances in Tissue Engineering & Regenerative Medicine: Open Access
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
